A phase II study of risk‐adapted intravenous melphalan in patients with AL amyloidosis
暂无分享,去创建一个
S. Paul | C. Tiley | H. Prince | J. Tate | D. Gill | J. Moore | P. Mollee | I. Cunningham | P. Cannell | S. Gibbons | Helen G Mar Fan
暂无分享,去创建一个
S. Paul | C. Tiley | H. Prince | J. Tate | D. Gill | J. Moore | P. Mollee | I. Cunningham | P. Cannell | S. Gibbons | Helen G Mar Fan